Additional Information
Book Details
Abstract
Richly illustrated and comprehensive in scope, Abdominal Imaging, 2nd Edition, by Drs. Dushyant V. Sahani and Anthony E. Samir, is your up-to-date, one-volume source for evaluating the full range of diagnostic, therapeutic, and interventional challenges in this fast-changing field. Part of the Expert Radiology series, this highly regarded reference covers all modalities and organ systems in a concise, newly streamlined format for quicker access to common and uncommon findings. Detailed, expert guidance, accompanied by thousands of high-quality digital images, helps you make the most of new technologies and advances in abdominal imaging.
- Offers thorough coverage of all diagnostic modalities for abdominal imaging: radiographs, fluoroscopy, ultrasound, CT, MRI, PET and PET/CT.
- Helps you select the best imaging approaches and effectively interpret your findings with a highly templated, well-organized, at-a-glance organization.
- Covers multi-modality imaging of the esophagus, stomach, small bowel, colon, liver, pancreas, gall bladder, bile ducts, spleen, pelvic lymph nodes, kidneys, urinary tract, prostate, and peritoneum.
- Includes new chapters on esophageal imaging; 5RECIST, WHO, and other response criteria; and a new section on oncologic imaging.
- Keeps you up to date with the latest developments in image-guided therapies, dual-energy CT, elastography, and much more.
- Features more than 2,400 high-quality images, including 240 images new to this edition.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | cover | ||
Inside Front Cover | ifc1 | ||
Abdominal Imaging | i | ||
Copyright Page | iv | ||
Dedication | v | ||
Editors | vii | ||
Preface | xviii | ||
Table Of Contents | xix | ||
1 Imaging Techniques | 1 | ||
1 Conventional Imaging of Abdomen | 2 | ||
1 Plain Radiography of the Abdomen | 3 | ||
Technical Aspects | 3 | ||
Pros and Cons | 3 | ||
Controversies | 3 | ||
Normal Anatomy | 4 | ||
Intraluminal Gas | 5 | ||
Extraluminal Gas | 5 | ||
Calcification | 5 | ||
Soft Tissues and Bone | 6 | ||
Artifacts | 6 | ||
Pathologic Findings | 6 | ||
Renal Colic | 6 | ||
Intestinal Obstruction | 7 | ||
Perforation of the Intestine | 7 | ||
Appendicitis | 7 | ||
Intussusception | 7 | ||
Body Packers | 7 | ||
Pathophysiology | 7 | ||
Small Bowel | 7 | ||
Colon | 8 | ||
Miscellaneous Findings | 8 | ||
Suggested Readings | 9 | ||
References | 9 | ||
2 Fluoroscopic Study of the Abdomen and Fluoroscopic Contrast Media | 10 | ||
Technical Aspects | 10 | ||
Fluoroscopy | 10 | ||
History | 10 | ||
Patient Preparation | 10 | ||
Fluoroscopic Examinations | 10 | ||
Gastrointestinal Fluoroscopic Procedures | 10 | ||
Genitourinary Fluoroscopic Procedures | 10 | ||
Interventional Procedures | 10 | ||
Other Examinations | 10 | ||
Fluoroscopic Contrast Agents | 11 | ||
Barium | 11 | ||
Water-Soluble Contrast Agents | 12 | ||
Gastrografin | 13 | ||
Oral Administration | 13 | ||
Enemas or Enterostomy Instillations | 13 | ||
Oral Gastrografin Indications | 14 | ||
Equipment Factors | 14 | ||
Patient Factors | 14 | ||
Side Effects | 14 | ||
Barium | 14 | ||
Iodinated Oral Contrast Media | 14 | ||
Pros and Cons | 14 | ||
Suggested Readings | 14 | ||
References | 15 | ||
2 Ultrasound | 16 | ||
3 Abdominal Ultrasound Imaging | 17 | ||
Basic Physics | 17 | ||
Definition | 17 | ||
Properties of Ultrasound | 17 | ||
Safety | 17 | ||
Instrumentation | 17 | ||
General Abdominal Ultrasonography | 17 | ||
Equipment | 18 | ||
Preparation for Examination | 18 | ||
Normal Ultrasound Image | 19 | ||
Liver | 19 | ||
Gallbladder and Bile Duct | 19 | ||
Pancreas | 19 | ||
Spleen | 20 | ||
Kidney and Adrenal Gland | 20 | ||
Ureters, Bladder and Prostate | 21 | ||
Scrotum | 21 | ||
Digestive Tract | 22 | ||
Retroperitoneal Great Vessels | 22 | ||
Abdominal Wall and Peritoneum | 22 | ||
Suggest Readings | 23 | ||
References | 23 | ||
4 Tissue Harmonic Imaging and Doppler Ultrasound Imaging | 24 | ||
Tissue Harmonic Imaging | 24 | ||
2 Nontraumatic Acute Abdomen | 93 | ||
6 Nontraumatic Acute Abdomen | 94 | ||
14 Ureteral and Kidney Stones | 95 | ||
Etiology | 95 | ||
Prevalence and Epidemiology | 95 | ||
Clinical Presentation | 95 | ||
Pathophysiology | 95 | ||
Imaging | 95 | ||
Radiography | 95 | ||
Computed Tomography | 95 | ||
Magnetic Resonance Imaging | 97 | ||
Ultrasonography | 97 | ||
Imaging Algorithm | 97 | ||
Differential Diagnosis | 98 | ||
Treatment | 98 | ||
Medical Treatment | 98 | ||
Surgical Treatment | 98 | ||
Suggested Readings | 99 | ||
References | 99 | ||
15 Acute Appendicitis | 100 | ||
Etiology | 100 | ||
Epidemiology | 100 | ||
Clinical Presentation | 100 | ||
Pathophysiology | 100 | ||
Pathology | 100 | ||
Imaging | 100 | ||
Radiography | 100 | ||
Computed Tomography | 100 | ||
Magnetic Resonance Imaging | 100 | ||
Ultrasonography | 101 | ||
Imaging Algorithm | 102 | ||
Differential Diagnosis | 102 | ||
Treatment | 103 | ||
Suggested Readings | 104 | ||
References | 104 | ||
16 Hollow Viscus Perforation | 105 | ||
Etiology | 105 | ||
Prevalence and Epidemiology | 105 | ||
Clinical Presentation | 105 | ||
Pathophysiology | 105 | ||
Pathology | 106 | ||
Imaging | 106 | ||
Radiography | 106 | ||
Computed Tomography | 106 | ||
Imaging Algorithm | 108 | ||
Differential Diagnosis | 109 | ||
Treatment | 109 | ||
Medical Treatment | 109 | ||
Surgical Treatment | 109 | ||
Suggested Readings | 109 | ||
References | 110 | ||
17 Acute Gastrointestinal Bleeding | 111 | ||
Etiology | 111 | ||
Prevalence and Epidemiology | 111 | ||
Clinical Presentation | 111 | ||
Pathophysiology | 111 | ||
Imaging | 111 | ||
Radiography | 111 | ||
Computed Tomography | 111 | ||
Nuclear Medicine | 112 | ||
Imaging Algorithm | 112 | ||
Differential Diagnosis | 113 | ||
Treatment | 113 | ||
Medical Treatment | 113 | ||
Surgical Treatment | 114 | ||
Suggested Readings | 115 | ||
References | 115 | ||
3 Esophagus and Stomach | 117 | ||
7 Esophagus and Stomach Imaging | 118 | ||
18 Esophageal Imaging | 119 | ||
Technical Aspects | 119 | ||
Anatomy | 119 | ||
Imaging | 119 | ||
Pathologic Conditions | 119 | ||
Benign Esophageal Tumors | 119 | ||
Mucosal Tumors | 119 | ||
Submucosal Tumors | 119 | ||
Leiomyoma | 120 | ||
Esophageal Cyst | 120 | ||
Fibrovascular Polyp | 120 | ||
Malignant Esophageal Tumors | 121 | ||
Esophageal Cancer | 121 | ||
Tumor Classification | 121 | ||
Node Classification | 122 | ||
Metastasis Classification | 122 | ||
Neuroendocrine Tumors | 122 | ||
Other Malignant Esophageal Tumors | 123 | ||
Other Esophageal Diseases | 123 | ||
Achalasia | 123 | ||
Esophageal Varices | 123 | ||
Esophageal Perforation | 123 | ||
Suggested Readings | 125 | ||
References | 125 | ||
19 Imaging of the Stomach and Duodenum | 126 | ||
Technical Aspects | 126 | ||
Technique | 126 | ||
Stomach Views | 126 | ||
Duodenum Views | 126 | ||
Single-Contrast Examination | 126 | ||
Normal Anatomy | 126 | ||
Patterns and Appearances on Barium Studies | 127 | ||
Gastric Ulcers | 127 | ||
Duodenal Ulcers | 128 | ||
Narrowing of the Stomach (Linitis Plastica Pattern) | 129 | ||
Filling Defects in the Stomach | 129 | ||
Thickening of Gastric Folds | 129 | ||
Extrinsic Lesions | 129 | ||
Widening of the Duodenal C Loop | 129 | ||
Computed Tomography of the Stomach | 129 | ||
Gastric Ulcer | 129 | ||
Generalized Gastric Wall Thickening | 130 | ||
Primary Malignant Neoplasms | 131 | ||
Gastric Lymphoma | 131 | ||
Submucosal Lesions | 132 | ||
Gastrointestinal Stromal Tumors | 132 | ||
Leiomyosarcoma | 132 | ||
Metastasis | 132 | ||
Miscellaneous Disorders | 132 | ||
Gastric Varices | 132 | ||
Gastric Distention | 133 | ||
Computed Tomography of the Duodenum | 133 | ||
Inflammatory Conditions | 134 | ||
Duodenal Diverticulum | 134 | ||
Neoplasm | 135 | ||
Malignant Tumors | 135 | ||
Secondary Involvement | 135 | ||
References | 136 | ||
8 Stomach Lesions | 137 | ||
20 Mucosal Diseases of the Stomach | 138 | ||
Malignant Mucosal Processes | 138 | ||
Etiology | 138 | ||
Prevalence and Epidemiology | 138 | ||
Benign Diseases Causing Mucosal Ulcerations | 138 | ||
Benign Diseases Causing Polyps and Masses | 138 | ||
Benign Diseases Causing Diffuse Mucosal Abnormalities | 138 | ||
Pathology | 139 | ||
Imaging | 139 | ||
Ulcers | 139 | ||
Radiography. | 139 | ||
Computed Tomography. | 139 | ||
Polyps and Masses | 140 | ||
4 Small Bowel and Colon | 161 | ||
10 Small Bowel | 162 | ||
24 Imaging the Small Bowel | 163 | ||
Fluoroscopic Small Bowel Imaging Techniques | 163 | ||
Small Bowel Follow-Through | 163 | ||
Fluoroscopic Enteroclysis | 163 | ||
Small Bowel Computed Tomography Techniques | 163 | ||
Abdominal and Pelvic Computed Tomography | 163 | ||
Computed Tomography Enterography | 163 | ||
Computed Tomography Enteroclysis | 165 | ||
Small Bowel Magnetic Resonance Imaging Techniques | 166 | ||
Magnetic Resonance Enterography | 166 | ||
Magnetic Resonance Enteroclysis | 167 | ||
Ultrasound Evaluation of Small Bowel | 167 | ||
Imaging | 169 | ||
Normal Appearance | 169 | ||
The Abnormal Small Bowel | 169 | ||
Nuclear Medicine Evaluation of Small Bowel | 169 | ||
Imaging of Inflammation and Infection | 170 | ||
Principle | 170 | ||
Image Interpretation | 170 | ||
Pros and Cons | 171 | ||
Imaging of Meckel’s Diverticulum | 171 | ||
5 Liver and Pancreas | 313 | ||
12 Liver | 314 | ||
35 Imaging of the Liver | 315 | ||
Ultrasound | 315 | ||
Technical Aspects | 315 | ||
Technique | 315 | ||
Patient Preparation and Positioning. | 315 | ||
Scanning Approach and Anatomic Overview. | 315 | ||
Normal Anatomy | 315 | ||
Relevant Morphologic Features | 315 | ||
Normal Hemodynamics | 315 | ||
Diffuse Liver Disease | 317 | ||
Computed Tomography | 317 | ||
Technical Aspects | 317 | ||
Dual-Phase Imaging | 318 | ||
Contrast Volume | 318 | ||
Technical Aspects for Image Postprocessing | 319 | ||
Postprocessing Techniques for Computed Tomography Angiography | 319 | ||
Advanced Postprocessing Applications | 320 | ||
Dual-Energy Computed Tomography | 321 | ||
Magnetic Resonance Imaging | 322 | ||
Indications | 322 | ||
Technical Aspects | 322 | ||
T1-Weighted Imaging | 322 | ||
T2-Weighted Imaging | 323 | ||
Contrast-Enhanced Imaging | 324 | ||
Gadolinium Contrast Agents | 325 | ||
Superparamagnetic Iron Oxide Particles (Ferumoxides) | 326 | ||
Technique Optimization and New Developments | 326 | ||
Diffusion Weighted Magnetic Resonance Imaging | 326 | ||
Elastography | 327 | ||
Nuclear Medicine | 328 | ||
Technical Aspects | 328 | ||
Radiopharmaceuticals | 328 | ||
Cholescintigraphy | 328 | ||
Patient Preparation | 328 | ||
Cholecystokinin and Morphine Sulfate. | 328 | ||
Indications | 329 | ||
Acute Cholecystitis | 329 | ||
Bile Leaks | 329 | ||
Acknowledgments | 329 | ||
Suggested Readings | 330 | ||
References | 330 | ||
36 Benign Focal Lesions | 332 | ||
Etiology | 332 | ||
Prevalence and Epidemiology | 332 | ||
Clinical Presentation | 332 | ||
Pathophysiology | 332 | ||
Pathology | 332 | ||
Imaging | 332 | ||
Computed Tomography | 332 | ||
Magnetic Resonance Imaging | 332 | ||
Ultrasonography | 332 | ||
Specific Lesions | 334 | ||
Simple (Bile Duct) Cyst | 334 | ||
Etiology | 334 | ||
Prevalence and Epidemiology | 334 | ||
Clinical Presentation | 334 | ||
Pathophysiology | 334 | ||
Pathology | 334 | ||
Liver Function | 334 | ||
Imaging | 334 | ||
Computed Tomography. | 334 | ||
Magnetic Resonance Imaging. | 334 | ||
Ultrasonography. | 335 | ||
Imaging Algorithm. | 335 | ||
Differential Diagnosis | 335 | ||
Treatment | 336 | ||
Medical Treatment. | 336 | ||
Surgical Treatment. | 336 | ||
Hepatic Hemangioma | 336 | ||
Etiology | 336 | ||
Prevalence and Epidemiology | 337 | ||
Clinical Presentation | 337 | ||
Pathophysiology | 337 | ||
Pathology | 337 | ||
Liver Function | 338 | ||
Imaging | 338 | ||
Computed Tomography. | 338 | ||
Magnetic Resonance Imaging. | 338 | ||
Ultrasonography. | 339 | ||
Imaging Algorithm. | 340 | ||
Differential Diagnosis | 340 | ||
Treatment | 340 | ||
Medical Treatment. | 340 | ||
Surgical Treatment. | 340 | ||
Hepatocellular Adenoma | 340 | ||
Etiology | 340 | ||
Prevalence and Epidemiology | 340 | ||
Clinical Presentation | 340 | ||
Pathophysiology | 341 | ||
Pathology | 341 | ||
Liver Function | 342 | ||
Imaging | 342 | ||
Computed Tomography. | 342 | ||
Magnetic Resonance Imaging. | 342 | ||
Ultrasonography. | 342 | ||
Imaging Algorithm. | 342 | ||
Differential Diagnosis | 342 | ||
Treatment | 342 | ||
Medical Treatment. | 342 | ||
Surgical Treatment. | 342 | ||
Focal Nodular Hyperplasia | 342 | ||
Etiology | 342 | ||
Prevalence and Epidemiology | 343 | ||
Clinical Presentation | 343 | ||
Pathophysiology | 343 | ||
Pathology | 343 | ||
Liver Function | 343 | ||
Imaging | 344 | ||
Computed Tomography. | 344 | ||
Magnetic Resonance Imaging. | 344 | ||
Ultrasonography. | 344 | ||
Imaging Algorithm. | 344 | ||
Differential Diagnosis | 344 | ||
Treatment | 345 | ||
Medical Treatment. | 345 | ||
Surgical Treatment. | 345 | ||
Large Benign Regenerative Nodules | 345 | ||
Etiology | 345 | ||
Prevalence and Epidemiology | 346 | ||
Clinical Presentation | 346 | ||
Pathophysiology | 346 | ||
Pathology | 346 | ||
Liver Function | 346 | ||
Imaging | 346 | ||
Computed Tomography. | 346 | ||
Magnetic Resonance Imaging. | 346 | ||
Ultrasonography. | 346 | ||
Imaging Algorithm. | 346 | ||
Differential Diagnosis | 346 | ||
Treatment | 347 | ||
Medical Treatment. | 347 | ||
Surgical Treatment. | 347 | ||
Pyogenic Hepatic Abscess | 347 | ||
Etiology | 347 | ||
Prevalence and Epidemiology | 347 | ||
Clinical Presentation | 347 | ||
Pathophysiology | 347 | ||
Pathology | 348 | ||
Liver Function | 348 | ||
Imaging | 348 | ||
Computed Tomography. | 348 | ||
Magnetic Resonance Imaging. | 348 | ||
Ultrasonography. | 348 | ||
Imaging Algorithm. | 348 | ||
Differential Diagnosis | 348 | ||
Treatment | 349 | ||
Medical Treatment. | 349 | ||
Surgical Treatment. | 349 | ||
Summary | 350 | ||
Suggested Readings | 351 | ||
References | 351 | ||
37 Malignant Focal Lesions | 353 | ||
Etiology | 353 | ||
Prevalence and Epidemiology | 353 | ||
Clinical Presentation | 353 | ||
Pathophysiology | 353 | ||
Pathology | 353 | ||
Liver Function | 353 | ||
Imaging | 353 | ||
Computed Tomography | 353 | ||
Magnetic Resonance Imaging | 353 | ||
Ultrasonography | 354 | ||
Positron Emission Tomography with Computed Tomography | 354 | ||
Specific Lesions | 354 | ||
Epithelioid Hemangioendothelioma | 354 | ||
Etiology | 354 | ||
Prevalence and Epidemiology | 354 | ||
Clinical Presentation | 354 | ||
Pathophysiology | 354 | ||
Pathology | 354 | ||
Liver Function | 354 | ||
Imaging | 354 | ||
Computed Tomography. | 354 | ||
Magnetic Resonance Imaging. | 354 | ||
Ultrasonography. | 354 | ||
Positron Emission Tomography With Computed Tomography. | 356 | ||
Imaging Algorithm. | 356 | ||
Differential Diagnosis | 356 | ||
Treatment | 356 | ||
Medical Treatment. | 356 | ||
Surgical Treatment. | 357 | ||
Angiosarcoma | 357 | ||
Etiology | 357 | ||
Prevalence and Epidemiology | 358 | ||
Clinical Presentation | 358 | ||
Pathophysiology | 358 | ||
Pathology | 358 | ||
Liver Function | 358 | ||
Imaging | 358 | ||
Computed Tomography. | 358 | ||
Magnetic Resonance Imaging. | 358 | ||
Ultrasonography. | 358 | ||
Positron Emission Tomography With Computed Tomography. | 359 | ||
Imaging Algorithm. | 359 | ||
Differential Diagnosis | 359 | ||
Treatment | 359 | ||
Medical Treatment. | 359 | ||
Surgical Treatment. | 359 | ||
Hepatocellular Carcinoma in the Noncirrhotic Liver | 359 | ||
Etiology | 359 | ||
Prevalence and Epidemiology | 359 | ||
Clinical Presentation | 359 | ||
Pathophysiology | 359 | ||
Pathology | 359 | ||
Liver Function | 359 | ||
Imaging | 359 | ||
Computed Tomography. | 359 | ||
Magnetic Resonance Imaging. | 359 | ||
Ultrasonography. | 360 | ||
Positron Emission Tomography With Computed Tomography. | 360 | ||
Imaging Algorithm. | 360 | ||
Differential Diagnosis | 360 | ||
Treatment | 360 | ||
Medical Treatment. | 360 | ||
Surgical Treatment. | 361 | ||
Fibrolamellar Hepatocellular Carcinoma | 361 | ||
Etiology | 361 | ||
Prevalence and Epidemiology | 361 | ||
Clinical Presentation | 361 | ||
Pathophysiology | 361 | ||
Pathology | 361 | ||
Liver Function | 361 | ||
Imaging | 361 | ||
Computed Tomography. | 361 | ||
Magnetic Resonance Imaging. | 361 | ||
Ultrasonography. | 361 | ||
Positron Emission Tomography With Computed Tomography. | 361 | ||
Imaging Algorithm. | 361 | ||
Differential Diagnosis | 361 | ||
Treatment | 363 | ||
Medical Treatment. | 363 | ||
Surgical Treatment. | 363 | ||
Hepatoblastoma | 364 | ||
Etiology | 364 | ||
Prevalence and Epidemiology | 364 | ||
Clinical Presentation | 364 | ||
Pathophysiology | 364 | ||
Pathology | 364 | ||
Liver Function | 364 | ||
Imaging | 364 | ||
Computed Tomography. | 364 | ||
Magnetic Resonance Imaging. | 364 | ||
Ultrasonography. | 364 | ||
Positron Emission Tomography With Computed Tomography. | 364 | ||
Imaging Algorithm. | 365 | ||
Differential Diagnosis | 365 | ||
Treatment | 365 | ||
Medical Treatment. | 365 | ||
Surgical Treatment. | 365 | ||
Lymphoma | 365 | ||
Etiology | 365 | ||
Prevalence and Epidemiology | 365 | ||
Clinical Presentation | 365 | ||
Pathophysiology | 365 | ||
Pathology | 365 | ||
Liver Function | 365 | ||
Imaging | 365 | ||
Computed Tomography. | 365 | ||
Magnetic Resonance Imaging. | 365 | ||
Ultrasonography. | 366 | ||
Positron Emission Tomography With Computed Tomography. | 366 | ||
Imaging Algorithm. | 366 | ||
Differential Diagnosis | 366 | ||
Treatment | 367 | ||
Medical Treatment. | 367 | ||
Surgical Treatment. | 367 | ||
Hepatic Metastases | 367 | ||
Etiology | 367 | ||
Prevalence and Epidemiology | 367 | ||
Clinical Presentation | 367 | ||
Pathophysiology | 367 | ||
Pathology | 367 | ||
Liver Function | 367 | ||
Imaging | 368 | ||
Computed Tomography. | 368 | ||
Magnetic Resonance Imaging. | 368 | ||
Ultrasonography. | 369 | ||
Positron Emission Tomography With Computed Tomography. | 369 | ||
Imaging Algorithm. | 369 | ||
Differential Diagnosis | 369 | ||
Treatment | 370 | ||
Medical Treatment. | 370 | ||
Surgical Treatment. | 370 | ||
Summary | 370 | ||
Suggested Readings | 372 | ||
References | 372 | ||
38 Fatty Liver Disease | 373 | ||
Etiology | 373 | ||
Prevalence and Epidemiology | 373 | ||
Clinical Presentation | 373 | ||
Pathology | 374 | ||
Imaging | 374 | ||
Radiography | 375 | ||
Computed Tomography | 375 | ||
Magnetic Resonance Imaging | 377 | ||
Ultrasound | 378 | ||
Nuclear Medicine | 380 | ||
Imaging Algorithm | 380 | ||
Hepatic Fat Detection | 380 | ||
Hepatic Fat Quantification | 381 | ||
Differential Diagnosis | 381 | ||
Treatment | 381 | ||
Medical Treatment | 381 | ||
Surgical Treatment | 381 | ||
Suggested Readings | 382 | ||
References | 382 | ||
39 Hepatic Iron Overload | 384 | ||
Etiology | 384 | ||
Prevalence and Epidemiology | 384 | ||
Clinical Presentation | 384 | ||
Pathology | 385 | ||
Imaging | 385 | ||
Radiography | 385 | ||
Computed Tomography | 386 | ||
Unenhanced Computed Tomography | 386 | ||
Contrast-Enhanced Computed Tomography | 386 | ||
Extrahepatic Findings. | 386 | ||
Computed Tomography Quantification of Hepatic Iron Overload. | 386 | ||
Magnetic Resonance Imaging | 386 | ||
Unenhanced Magnetic Resonance Imaging | 386 | ||
Contrast-Enhanced Magnetic Resonance Imaging | 386 | ||
Magnetic Resonance Features of Extrahepatic Iron Overload. | 387 | ||
Magnetic Resonance Quantification of Hepatic Iron Overload. | 387 | ||
Ultrasound | 389 | ||
Nuclear Medicine | 389 | ||
Imaging Algorithm | 389 | ||
Differential Diagnosis | 390 | ||
Treatment | 390 | ||
Medical Treatment | 390 | ||
Surgical Treatment | 390 | ||
Suggested Readings | 391 | ||
References | 391 | ||
40 Hepatic Storage Disorders | 393 | ||
Etiology | 393 | ||
Pathogenesis | 393 | ||
Wilson’s Disease | 393 | ||
Alpha-1 Antitrypsin Deficiency | 393 | ||
6 Gallbladder, Bile Ducts, and Spleen | 565 | ||
14 Gallbladder and Bile Ducts | 566 | ||
52 Dilated Bile Ducts | 567 | ||
Etiology | 567 | ||
Prevalence and Epidemiology | 567 | ||
Clinical Presentation | 567 | ||
Pathophysiology | 570 | ||
Pathology | 570 | ||
Imaging | 570 | ||
Radiography | 571 | ||
Computed Tomography | 571 | ||
Magnetic Resonance Imaging and Magnetic Resonance Cholangiopancreatography | 572 | ||
Ultrasonography | 574 | ||
Nuclear Medicine | 574 | ||
Positron Emission Tomography with Computed Tomography | 574 | ||
Imaging Algorithm | 575 | ||
Differential Diagnosis | 575 | ||
Treatment | 576 | ||
Specific Lesions | 579 | ||
Choledocholithiasis | 579 | ||
Etiology | 579 | ||
Epidemiology and Definitions | 579 | ||
Clinical Presentation | 579 | ||
Pathophysiology | 579 | ||
Imaging | 579 | ||
Computed Tomography. | 579 | ||
Magnetic Resonance Imaging and Magnetic Resonance Cholangiopancreatography. | 579 | ||
Ultrasonography. | 579 | ||
Differential Diagnosis | 580 | ||
Treatment | 580 | ||
Medical Treatment. | 580 | ||
Surgical Treatment. | 580 | ||
Postoperative Bile Duct Strictures | 580 | ||
Etiology | 580 | ||
Prevalence and Epidemiology | 581 | ||
Clinical Presentation | 581 | ||
Pathophysiology | 581 | ||
Pathology | 581 | ||
Imaging | 581 | ||
Radiography. | 581 | ||
Computed Tomography. | 581 | ||
Magnetic Resonance Imaging and Magnetic Resonance Cholangiopancreatography. | 581 | ||
Nuclear Medicine. | 581 | ||
Treatment | 582 | ||
Medical Treatment. | 582 | ||
Surgical Treatment. | 582 | ||
Primary Sclerosing Cholangitis | 582 | ||
Etiology, Prevalence, and Epidemiology | 582 | ||
Clinical Presentation | 582 | ||
Pathophysiology | 583 | ||
Pathology | 583 | ||
Imaging | 583 | ||
Radiography. | 583 | ||
Computed Tomography and Magnetic Resonance Imaging. | 583 | ||
Ultrasonography. | 583 | ||
Differential Diagnosis | 583 | ||
Treatment | 584 | ||
Medical Treatment. | 584 | ||
Surgical Treatment. | 585 | ||
Suggested Readings | 585 | ||
References | 585 | ||
53 Tumors of the Gallbladder | 587 | ||
Etiology | 587 | ||
Prevalence and Epidemiology | 587 | ||
Clinical Presentation | 587 | ||
Pathophysiology | 587 | ||
Pathology | 587 | ||
Imaging | 587 | ||
Radiography | 587 | ||
Computed Tomography | 588 | ||
Magnetic Resonance Imaging | 588 | ||
Ultrasonography | 588 | ||
Nuclear Medicine | 589 | ||
Positron Emission Tomography with Computed Tomography | 589 | ||
Imaging Algorithm | 589 | ||
Differential Diagnosis | 589 | ||
Treatment | 590 | ||
Medical Treatment | 590 | ||
Surgical Treatment | 590 | ||
Suggested Readings | 593 | ||
References | 593 | ||
54 Intrahepatic Bile Duct Tumors | 594 | ||
Etiology | 594 | ||
Prevalence and Epidemiology | 594 | ||
Clinical Presentation | 594 | ||
Pathophysiology | 594 | ||
Pathology | 594 | ||
Imaging | 594 | ||
Radiography | 595 | ||
Computed Tomography | 596 | ||
Magnetic Resonance Imaging | 596 | ||
Ultrasonography | 596 | ||
Nuclear Medicine | 597 | ||
Positron Emission Tomography with Computed Tomography | 597 | ||
Imaging Algorithm | 597 | ||
Differential Diagnosis | 597 | ||
Treatment | 598 | ||
Medical Treatment | 598 | ||
Surgical Treatment | 599 | ||
Suggested Readings | 599 | ||
References | 599 | ||
55 Extrahepatic Bile Duct Tumors | 601 | ||
Etiology | 601 | ||
Prevalence and Epidemiology | 601 | ||
Clinical Presentation | 601 | ||
Pathophysiology | 601 | ||
Pathology | 601 | ||
Imaging | 602 | ||
Radiography | 602 | ||
Computed Tomography | 602 | ||
Magnetic Resonance Imaging | 603 | ||
Ultrasonography | 604 | ||
Nuclear Medicine | 604 | ||
Positron Emission Tomography with Computed Tomography | 605 | ||
Imaging Algorithm | 605 | ||
Differential Diagnosis | 605 | ||
Treatment | 606 | ||
Medical Treatment | 606 | ||
Surgical Treatment | 607 | ||
Suggested Readings | 607 | ||
References | 608 | ||
56 Diffuse Gallbladder Wall Thickening | 609 | ||
Normal Gallbladder Wall | 609 | ||
Thickened Gallbladder Wall | 609 | ||
Primary Gallbladder Wall Thickening | 610 | ||
Acute Cholecystitis | 610 | ||
Etiology | 610 | ||
7 Abdominal and Pelvic Lymph Nodes | 699 | ||
16 Abdominal and Pelvic Lymph Nodes | 700 | ||
61 Lymph Node Imaging Techniques and Clinical Role | 701 | ||
Lymph Node Imaging Techniques | 701 | ||
Normal Anatomy | 701 | ||
Retrocrural Nodes | 703 | ||
Gastric Nodes | 703 | ||
Gastrohepatic Ligament Nodes | 703 | ||
Portohepatic Nodes | 703 | ||
Pancreaticoduodenal Nodes | 703 | ||
Perisplenic Nodes | 703 | ||
Mesenteric Nodes | 703 | ||
Celiac, Superior Mesenteric, and Inferior Mesenteric Nodes | 703 | ||
Para-Aortic Nodes | 704 | ||
External Iliac Nodes | 704 | ||
Internal Iliac Nodes | 704 | ||
Common Iliac Nodes | 705 | ||
Inguinal Lymph Nodes | 705 | ||
Computed Tomography | 706 | ||
Technique | 706 | ||
Normal Anatomy | 706 | ||
Measurement of Nodal Size. | 706 | ||
Mimics of Abnormal Lymph Nodes on Computed Tomography. | 706 | ||
Pathophysiology and Pathology | 706 | ||
Ultrasonography | 707 | ||
Normal Anatomy | 707 | ||
Pathophysiology and Pathology | 707 | ||
Magnetic Resonance Imaging | 708 | ||
Diffusion Weighted Imaging | 708 | ||
Magnetic Resonance Lymphangiography | 708 | ||
Normal Anatomy | 708 | ||
Pathophysiology and Pathology | 709 | ||
Positron Emission Tomography | 710 | ||
Normal Anatomy | 710 | ||
Pathophysiology and Pathology | 710 | ||
Clinical Role of Lymph Node Imaging | 710 | ||
Benign Diseases of Lymph Nodes | 711 | ||
Infective and Noninfective Lymphadenitis | 711 | ||
Infective Lymphadenitis | 711 | ||
8 Urogenital Imaging | 727 | ||
17 Kidneys and Urinary Tract | 728 | ||
62 Imaging of the Kidneys and Urinary Tract | 729 | ||
Anatomy Overview | 729 | ||
The Kidney | 729 | ||
Introduction to Renal Imaging Modalities | 729 | ||
Radiography | 729 | ||
Intravenous Urography | 730 | ||
Ultrasonography | 731 | ||
Technique | 731 | ||
Indications | 731 | ||
Stones | 731 | ||
Obstruction | 731 | ||
Infection | 732 | ||
Tumors | 733 | ||
Renal Cystic Disease | 733 | ||
Renal Parenchymal Disease | 733 | ||
Vascular Abnormalities | 733 | ||
Transplants | 734 | ||
Computed Tomography | 736 | ||
Technical Aspects | 736 | ||
Specific Indications and Techniques | 736 | ||
Urolithiasis and Suspected Renal Colic | 736 | ||
Renal Mass Characterization | 737 | ||
Hematuria and Evaluation for Urothelial Neoplasm | 738 | ||
Preoperative Planning (Nephron-Sparing Surgery and Renal Donor Surgery) | 738 | ||
Computed Tomography Cystography | 739 | ||
Trauma | 740 | ||
Infection | 740 | ||
Magnetic Resonance Imaging | 740 | ||
Technical Aspects | 740 | ||
Morphologic Magnetic Resonance Imagine of the Upper Urinary Tract, Ureters, and Bladder | 740 | ||
Magnetic Resonance Urography | 741 | ||
Pathophysiology and Pathology | 741 | ||
Solid Mass Characterization | 741 | ||
Staging of Renal Cell Carcinoma | 741 | ||
Cystic Mass Evaluation | 741 | ||
Simple Cysts. | 741 | ||
Complex Cysts. | 741 | ||
Evaluation of the Urinary Tract and Urothelium With Magnetic Resonance Imaging Urography | 742 | ||
Stone Detection. | 742 | ||
Noncalculous Causes of Urinary Tract Obstruction. | 742 | ||
Congenital Anomalies. | 742 | ||
Evaluation of the Bladder | 742 | ||
Magnetic Resonance Imaging of Bladder Cancer. | 742 | ||
Renal Magnetic Resonance Angiography. | 743 | ||
Nuclear Imaging | 744 | ||
Technical Aspects | 744 | ||
9 Abdominal Wall and Hernias | 997 | ||
26 Abdominal Wall and Hernias | 998 | ||
83 Neoplastic and Non-neoplastic Conditions of the Abdominal Wall | 999 | ||
Non-neoplastic Conditions | 999 | ||
Abdominal Wall InflamMation, Infection, and Fluid Collection | 999 | ||
Etiology | 999 | ||
Prevalence and Epidemiology | 999 | ||
Clinical Presentation | 999 | ||
Pathology | 999 | ||
Imaging | 999 | ||
Radiography. | 999 | ||
Computed Tomography. | 999 | ||
Magnetic Resonance Imaging. | 999 | ||
Ultrasonography. | 999 | ||
Imaging Algorithm. | 999 | ||
Differential Diagnosis | 999 | ||
Treatment | 1001 | ||
Traumatic Abnormalities, Including Abdominal Wall Hematoma | 1001 | ||
Etiology | 1001 | ||
Prevalence and Epidemiology | 1001 | ||
Clinical Presentation | 1001 | ||
Pathology | 1001 | ||
Imaging | 1001 | ||
Computed Tomography. | 1001 | ||
Magnetic Resonance Imaging. | 1002 | ||
Ultrasonography. | 1002 | ||
Imaging Algorithm. | 1002 | ||
Differential Diagnosis | 1002 | ||
Treatment | 1002 | ||
Endometriomas | 1003 | ||
10 Oncologic Imaging | 1027 | ||
27 General Concepts | 1028 | ||
85 Response Evaluation Criteria in Solid Tumors, World Health Organization, and Other Response Criteria | 1029 | ||
Response Criteria Based on Tumor Burden Measurement | 1029 | ||
World Health Organization Criteria | 1029 | ||
Response Evaluation Criteria in Solid Tumors Criteria | 1029 | ||
RECIST 1.0 | 1029 | ||
RECIST 1.1 | 1029 | ||
Measurability of Tumor Burden | 1030 | ||
Target Lesion (Measurable Lesion) | 1030 | ||
Nonmeasurable Lesion | 1030 | ||
Tumor Response Evaluation | 1031 | ||
Response Categories | 1031 | ||
Target Lesion Evaluation | 1031 | ||
Nontarget Lesion Evaluation | 1031 | ||
Overall Response | 1031 | ||
Role of Volumetric and Functional Imaging | 1031 | ||
Response Assessment Based on Tumor Density Measurement | 1031 | ||
Choi Criteria | 1031 | ||
Modified Response Evaluation Criteria in Solid Tumors | 1032 | ||
Response Assessment Based on Fluorodeoxyglucose With Positron Emission Tomography: European Organization for Research and Treatment of Cancer Criteria | 1033 | ||
Response Assessment Based on Fluorodeoxyglucose–Positron Emission Tomography: Positron Emission Tomography Response Criteria in Solid Tumors | 1033 | ||
Response Criteria for Lymphoma | 1034 | ||
Future Trends | 1036 | ||
Suggested Readings | 1036 | ||
References | 1037 | ||
86 Image-Guided Therapy | 1038 | ||
Image-Guided Treatment Options | 1038 | ||
Imaging Protocol | 1039 | ||
Imaging: Pretreatment Evaluation | 1039 | ||
Tumor Staging | 1039 | ||
Tumor Location | 1040 | ||
Local Tumor Invasion and Metastatic Disease | 1041 | ||
Vascular Anatomy | 1042 | ||
Tumor Metabolism | 1042 | ||
Estimation of Functional Reserve | 1043 | ||
Imaging: Posttreatment Evaluation | 1044 | ||
Imaging Appearances | 1044 | ||
Percutaneous Ablation | 1044 | ||
Intra-Arterial Therapies | 1046 | ||
Image-Guided Radiation Therapy | 1047 | ||
Monitoring Response to Loco-Regional Therapies | 1048 | ||
Complications | 1049 | ||
Advanced Imaging Methods | 1049 | ||
Postprocessing Techniques | 1049 | ||
Tumor Volumetry | 1049 | ||
Necrosis Quantification | 1051 | ||
Dual-Energy Computed Tomography | 1051 | ||
Hepatobiliary Magnetic Resonance Contrast Agents | 1051 | ||
Functional Magnetic Resonance Technique | 1051 | ||
References | 1052 | ||
Index | 1055 | ||
A | 1055 | ||
B | 1057 | ||
C | 1058 | ||
D | 1062 | ||
E | 1063 | ||
F | 1064 | ||
G | 1064 | ||
H | 1065 | ||
I | 1067 | ||
J | 1068 | ||
K | 1068 | ||
L | 1068 | ||
M | 1069 | ||
N | 1071 | ||
O | 1071 | ||
P | 1072 | ||
R | 1074 | ||
S | 1075 | ||
T | 1077 | ||
U | 1078 | ||
V | 1079 | ||
W | 1079 | ||
X | 1079 | ||
Y | 1079 | ||
Z | 1079 | ||
Inside Back Cover | ibc1 |